Marsh
MRSH
$192.01
+0.95%
Marsh is a global professional services firm specializing in risk management, insurance broking, reinsurance, and human capital consulting, operating through its Marsh, Guy Carpenter, Mercer, and Oliver Wyman brands. As one of the world's largest insurance brokers, it holds a dominant market position with a diversified revenue base, generating roughly half of its revenue outside the US. The current investor narrative centers on the company's ability to sustain organic growth amid a hardening insurance market, while also navigating margin pressures from investments in technology and talent. Recent quarterly results showed a 7.6% year-over-year revenue increase, and the stock has rallied strongly over the past three months, reflecting optimism about continued demand for its advisory services.…
MRSH
Marsh
$192.01
Investment Opinion: Should I buy MRSH Today?
We rate Marsh as a Hold. The company has strong fundamentals with 7.6% revenue growth and improving margins, but the stock is fairly valued to slightly overvalued at current levels. The average analyst target of $206.48 implies a 7.5% upside, which is modest given the risks. The consensus recommendation is 'Hold', reflecting a balanced view.
Sign up to view all
MRSH 12-Month Price Forecast
The AI assessment is neutral, reflecting a balanced risk/reward profile. Marsh has solid growth and profitability, but the valuation is not cheap, and the PEG ratio signals high expectations. The stock is likely to perform in line with the market over the next 12 months, with a slight upside bias if growth continues. To upgrade to bullish, we would need to see revenue growth above 8% and margin expansion. To downgrade to bearish, we would need to see growth decelerate below 5% or a significant deterioration in margins.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Marsh's 12-month outlook, with a consensus price target around $206.48 and implied upside of +7.5% versus the current price.
Average Target
$206.48
0 analysts
Implied Upside
+7.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$182 - $238
Analyst target range
The target price range spans from $182.00 (low) to $238.00 (high), representing a wide spread of 30.8% from low to high, which signals significant uncertainty about the stock's future performance. The high target of $238 implies a 23.9% upside, likely assuming continued strong growth and margin expansion, while the low target of $182 suggests a 5.2% downside, possibly reflecting concerns about competitive pressures or a cyclical downturn. Recent institutional ratings show a mix of actions, with Citigroup upgrading from Neutral to Buy in May 2026, while others like Mizuho and Morgan Stanley maintain neutral stances, indicating a lack of strong conviction in either direction.
Bulls vs Bears: MRSH Investment Factors
Marsh presents a compelling growth story with strong revenue momentum, a dominant market position, and improving profitability. However, the stock's valuation is stretched, with a PEG ratio of 7.85x and a forward PE of 16.8x that already prices in significant earnings growth. The bull case is supported by solid fundamentals and analyst upside, while the bear case centers on valuation risk and potential margin compression. Currently, the evidence slightly favors the bull side due to the company's consistent execution and defensive characteristics, but the key tension is whether Marsh can sustain its growth trajectory to justify its premium valuation. If growth decelerates or margins disappoint, the stock could face multiple compression.
Bullish
- Strong Revenue Growth: Q1 2026 revenue grew 7.6% YoY to $7.60B, with all segments contributing. This broad-based growth demonstrates the resilience of the business across insurance broking, consulting, and reinsurance.
- Dominant Market Position: As one of the world's largest insurance brokers, Marsh benefits from scale, brand trust, and a diversified revenue base with ~50% from outside the US, reducing geographic concentration risk.
- Improving Profitability: Operating margin expanded to 23.1% in Q1 2026, up from 18.8% in Q4 2025, driven by operational leverage and cost discipline. Net margin also improved to 15.1% from 12.4%.
- Analyst Upside Potential: The average analyst target of $206.48 implies a 7.5% upside from the current price of $192.01, with a high target of $238 suggesting 23.9% upside if the bull case materializes.
Bearish
- High Valuation Multiples: The trailing PE of 21.9x and forward PE of 16.8x are above historical averages, and the PEG ratio of 7.85x suggests the stock is overvalued relative to its growth rate, implying high market expectations.
- Elevated Debt Levels: Debt-to-equity ratio of 1.42 indicates significant leverage, which could strain cash flows if interest rates remain high or earnings decline, increasing financial risk.
- Margin Pressure from Investments: The company is investing heavily in technology and talent, which could compress margins in the near term. Q1 2026 gross margin of 45.6% is below the 2025 peak of 45.5%, showing potential pressure.
- Mixed Analyst Sentiment: The consensus recommendation is 'Hold' with a mean score of 2.52, and recent actions show only one upgrade (Citigroup) while others maintain neutral stances, indicating lack of strong conviction.
MRSH Technical Analysis
Marsh's stock is in a clear uptrend, with the price at $192.01 as of August 21, 2026, representing a 1.8% gain over the past year. The stock is trading at 90.3% of its 52-week range (between $156.60 and $212.65), indicating it is near the upper end of its range, which typically signals strong momentum but also potential overextension. The 52-week low of $156.60 was set in June 2026, and the stock has since recovered sharply, suggesting a robust bullish trend.
Beta
0.58
0.58x market volatility
Max Drawdown
-17.1%
Largest decline past year
52-Week Range
$157-$211
Price range past year
Annual Return
—
Cumulative gain past year
| Period | MRSH Return | S&P 500 |
|---|---|---|
| 1m | +9.1% | +3.6% |
| 3m | +17.0% | +2.7% |
| 6m | +7.1% | +11.4% |
| 1y | — | +18.7% |
| ytd | — | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MRSH Fundamental Analysis
Marsh's revenue trajectory is solidly growing, with the most recent quarter (Q1 2026) reporting revenue of $7.597 billion, a 7.59% year-over-year increase. This growth is consistent with the prior year's trend, where quarterly revenues ranged from $6.067 billion in Q4 2024 to $7.061 billion in Q1 2025, showing steady expansion. The growth is driven by all segments, with Marsh Insurance Group contributing $8.748 billion, Mercer $1.661 billion, Guy Carpenter $1.269 billion, and Oliver Wyman $897 million, indicating broad-based strength across the business.
Quarterly Revenue
$7.6B
2026-03
Revenue YoY Growth
+7.6%
YoY Comparison
Gross Margin
45.6%
Latest Quarter
Free Cash Flow
$4.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MRSH Overvalued?
Given Marsh's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 21.88x, while the forward PE is 16.83x, implying the market expects significant earnings growth. The gap between trailing and forward PE suggests an anticipated EPS increase of about 30%, which is optimistic but supported by the company's strong growth trajectory. The PEG ratio of 7.85x, however, suggests that the stock may be overvalued relative to its growth rate, as a PEG above 1 typically indicates the market is pricing in high expectations.
PE
21.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 17x~44x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a high debt-to-equity ratio of 1.42, which increases interest expense and financial fragility. The company's net margin of 15.4% is solid, but any downturn in revenue could pressure earnings given the fixed interest costs. Additionally, the payout ratio of 40.8% indicates a commitment to dividends, which could limit flexibility in a downturn. The current ratio of 1.10 suggests adequate liquidity, but it is not overly strong, and cash flow generation is critical to service debt.